BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 26, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 16, 2008
View Archived Issues
SVV-001 studied in experimental medulloblastoma in mice
Read More
Renovo presents results from Juvista and Zesteem trials
Read More
Rigel presents preclinical data on novel JAK2 inhibitor R-723
Read More
Qnexa meets primary endpoint in 28-week EQUATE study
Read More
Xoma provides preclinical animal data for diabetes drug XOMA-052
Read More
Valeant to acquire Dow Pharmaceutical Sciences for USD 285 million
Read More
IDMC recommends continuation of Seattle Genetics' phase IIb trial of lintuzumab in AML
Read More
Pharmacokinetic data for retigabine therapy disclosed
Read More
Nile presents results from phase Ib safety and PK study of CD-NP
Read More
Nuvelo reports encouraging results from phase I NU-206 trial in healthy volunteers
Read More
Phase III data show paliperidone's efficacy and tolerability in schizophrenia
Read More
PolyMedix announces positive phase I PMX-30063 data
Read More
ZymoGenetics reports favorable phase IIIb Recothrom results
Read More
Amylin, Lilly and Alkermes present update on DURATION clinical program for Byetta
Read More
FDA approves Pegintron/Rebetol combination in pediatric HCV patients
Read More
German regulatory authority approves CureVac's CTA to initiate phase I clinical study of CV-9103
Read More
SkyePharma and Somnus successfully complete phase I trial of SKP-1041 for sleep maintenance
Read More
Affiris initiates preclinical development of Parkinson's vaccine PD-01
Read More
Galmed successfully completes phase I trial of aramchol for fatty liver disease
Read More
Santhera completes recruitment into phase III MICONOS trial of SNT-MC17
Read More
Responses seen with afutuzumab in patients with CD20+ non-Hodgkin's lymphoma
Read More
TG-101348 appears well tolerated, decreases spleen size in myelofibrosis patients
Read More
Abraxis BioScience launches Abraxane in the European Union
Read More
Novel therapeutic agents for GERD disclosed in recent AstraZeneca patent
Read More
New antidiabetic agents disclosed in recent Merck Frosst patent
Read More
Recent Roche patent reports new agents for obesity
Read More
Rigel presents clinical data on fostamatinib disodium in B-cell NHL
Read More
